VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

Advanced Therapies Week 2022 | Key developments in the future of advanced therapies

Lavakumar Karyampudi, PhD, Moffitt Cancer Center, Tampa, FL, provides an overview of the topics discussed during the session on cell and gene therapies of the future at Advanced Therapies Week 2022. Dr Karyampudi highlights the development of hematopoietic stem cell gene therapy for rare disease, optimizing the yield of lentiviral vectors for gene therapies, as well as strategies to decrease manufacturing times in the production of cell and gene therapies. This interview took place at Advanced Therapies Week 2022.

Disclosures

Lavakumar Karyampud, PhD, is an employee of Moffitt Cancer Center.